Biocon

Biocon is a biopharmaceutical company focused on discovery, development, manufacturing and commercialization of biotechnology-based therapies. It operates across four segments: Biosimilars, Generics, Novel Biologics and Research Services. The company develops insulin products, monoclonal antibodies and other therapeutic proteins, including biosimilars, aimed at diabetes, oncology, immunology and autoimmune diseases. Through its subsidiary Syngene, Biocon provides integrated contract research and manufacturing services to the pharma industry. The group maintains substantial manufacturing capacity and serves markets in India and abroad, including the United States and Europe. A key subsidiary, Biocon Biologics, specializes in biosimilars and complex biologics, developing and commercializing a differentiated portfolio of biosimilars, novel biologics and APIs for global markets. The company emphasizes expanding patient access to affordable biologic therapies through its biosimilars and cost-effective development capabilities.